戴晓敏;姜林娣;
DAI Xiaomin;JIANG Lindi;Department of Rheumatology, Zhongshan Hospital, Fudan University;

• 1:复旦大学附属中山医院风湿免疫科

摘要(Abstract)：

本文通过临床伦理学视角,探讨风湿免疫性疾病患者临床治疗决策中的伦理问题及应对策略。采用"四主题理论"模型,分别从医疗适用性、患者偏好、生命质量、情境特征等主题切入,提炼伦理问题,查找循证证据,倾听患者意愿,促进医患双方共同参与、决策临床问题。
From the perspective of clinical ethics, this article aimed to identify ethical issues and explore resolutions during decision-making process of treatment strategies in patients with rheumatic diseases. We elaborated the topics of medical indications, preference of patients, quality of life, and contextual features by using the model of “four-topics theory”. Its application helped to identify and refine ethical issues, search and explore medical evidence, listen to the voice of patients, and finally promote the doctor-patient mutual participation and shared decision-making.

关键词(KeyWords)： 临床伦理学;临床决策;风湿免疫性疾病
clinical ethics;decision-making;rheumatic diseases

Abstract:

Keywords:

基金项目(Foundation): 上海市教育科学研究一般项目(C2021243);; 复旦大学上海医学院2019年医学人文教育和医学专业课程思政研究项目~~

作者(Authors): 戴晓敏;姜林娣;
DAI Xiaomin;JIANG Lindi;Department of Rheumatology, Zhongshan Hospital, Fudan University;

参考文献(References)：

• [1] Jonsen AR.A short history of medical ethics[M].New York:Oxford University Press,1999.
• [2] 张新庆，李传俊，蔡笃坚.30年来我国临床伦理研究主题之特点与反思——基于《中国医学伦理学》刊登论文的分析[J].中国医学伦理学，2018,31:461- 464.Zhang XQ,Li CJ,Cai DJ.Characteristic of the Research Themes and Reflections on Clinical Ethics in China within Thirty Years:An Analysis Based on the Published Paper of Chinese Medical Ethics[J].Zhongguo Yixue Lunlixue,2018,31:461- 464.
• [3] Jonsen AR,Siegler M,Winslade WJ.Clinical ethics:a practical approach to ethical decisions in clinical medicine[M].8th ed.New York:McGraw-Hill Education,2015.
• [4] Shaban A,Leira EC.Neurological Complications in Patients with Systemic Lupus Erythematosus[J].Curr Neurol Neurosci Rep,2019,19:97.
• [5] Bertsias GK,Ioannidis JP,Aringer M,et al.EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations:report of a task force of the EULAR standing committee for clinical affairs[J].Ann Rheum Dis,2010,69:2074- 2082.
• [6] Ruiz-Arruza I,Lozano J,Cabezas-Rodriguez I,et al.Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control:An Observational Study[J].Arthritis Care Res(Hoboken),2018,70:582- 591.
• [7] Legge A,Doucette S,Hanly JG.Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus[J].J Rheumatol,2016,43:1050- 1056.
• [8] Dubovsky AN,Arvikar S,Stern TA,et al.The neuropsychiatric complications of glucocorticoid use:steroid psychosis revisited[J].Psychosomatics,2012,53:103- 115.
• [9] Fanouriakis A,Kostopoulou M,Alunno A,et al.2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J].Ann Rheum Dis,2019,78:736- 745.